This pocketbook summarises the latest evidence-based and practical information on the use of systemic therapies in the management of non-small cell lung cancer (NSCLC) for early stage, locally advanced, and metastatic disease.
This pocketbook summarises the latest evidence-based and practical information on the use of systemic therapies in the management of non-small cell lung cancer (NSCLC) for early stage, locally advanced, and metastatic disease.
Giuseppe Giaccone, M.D., Ph.D. is an internationally recognized expert in the field of lung cancer and developmental therapeutics. Dr. Giaccone received his M.D. cum laude from the University of Torino Medical School in 1980, followed by training in clinical oncology and internal medicine, which he completed at the University of Torino in 1988. He spent the next two years in the NCI's Medical Oncology Branch. Following his training at the NCI, Dr. Giaccone received his Ph.D. from the Free University Medical Center in Amsterdam, The Netherlands. He then served as a senior medical oncologist at the Medical Center from 1990 to 2000, when he was appointed Professor of Medical Oncology. Dr. Giaccone became Head of the Center's Department of Medical Oncology in 2003. Dr. Giaccone has published more than 400 peer-reviewed papers and contributed to more than 30 book chapters. He has also played a major role in the European Organization for Research and Treatment of Cancer (EORTC).
Inhaltsangabe
* 1: Adi F. Gazdar, Jill E. Larsen, and John D. Minna: Molecular biology of lung cancer for the clinician * 2: Sofie De Craene, Kurt G Tournoy, and Jan P. van Meerbeeck: Staging of lung cancer * 3: Benjamin Besse and Jean Charles Soria: Systemic therapy of early stage NSCLC * 4: Margaret Edwards and Hak Choy: Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) * 5: Taylor M. Ortiz and Pasi A. Jänne: Systemic therapy of advanced NSCLC, efficacy, and toxicity * 6: Paul Wheatley-Price and Frances A. Shepherd: Systemic therapy for recurrent NSCLC, efficacy, and toxicity * 7: Paul Baas and Wilma Uyterlinde: Palliative care in NSCLC * 8: Arun Rajan and Giuseppe Giaccone: Development of new therapeutic agents for treatment of NSCLC
* 1: Adi F. Gazdar, Jill E. Larsen, and John D. Minna: Molecular biology of lung cancer for the clinician * 2: Sofie De Craene, Kurt G Tournoy, and Jan P. van Meerbeeck: Staging of lung cancer * 3: Benjamin Besse and Jean Charles Soria: Systemic therapy of early stage NSCLC * 4: Margaret Edwards and Hak Choy: Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) * 5: Taylor M. Ortiz and Pasi A. Jänne: Systemic therapy of advanced NSCLC, efficacy, and toxicity * 6: Paul Wheatley-Price and Frances A. Shepherd: Systemic therapy for recurrent NSCLC, efficacy, and toxicity * 7: Paul Baas and Wilma Uyterlinde: Palliative care in NSCLC * 8: Arun Rajan and Giuseppe Giaccone: Development of new therapeutic agents for treatment of NSCLC
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
